These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29382036)

  • 1. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
    Restivo DA; Panebianco M; Casabona A; Lanza S; Marchese-Ragona R; Patti F; Masiero S; Biondi A; Quartarone A
    Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29382036
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin in the Management of Sialorrhoea in Acquired Brain Injury.
    Carrol A; McGlone B
    Ir Med J; 2016 Jun; 109(6):425. PubMed ID: 27814442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders.
    Porta M; Gamba M; Bertacchi G; Vaj P
    J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):538-40. PubMed ID: 11254784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M; Di Rienzo F; Fontana A; Copetti M; Pellegrini F; Intiso D
    Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated treatments of drooling with botulinum toxin B in neurology.
    Møller E; Daugaard D; Holm O; Winge K; Bardow A; Lykkeaa J; Belhage B; Bakke M
    Acta Neurol Scand; 2015 Jan; 131(1):51-7. PubMed ID: 25270197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.
    Giess R; Naumann M; Werner E; Riemann R; Beck M; Puls I; Reiners C; Toyka KV
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):121-3. PubMed ID: 10864618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands.
    Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R
    Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type-A (Botox-A) injections for treatment of sialorrhoea in adults: a New Zealand study.
    Shetty S; Dawes P; Ruske D; Al-qudah M; Lyons B
    N Z Med J; 2006 Aug; 119(1240):U2129. PubMed ID: 16924280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience.
    Martínez-Poles J; Nedkova-Hristova V; Escribano-Paredes JB; García-Madrona S; Natera-Villalba E; Estévez-Fraga C; López-Sendón Moreno JL; Avilés-Olmos I; Sánchez Díaz G; Martínez Castrillo JC; Alonso-Canovas A
    Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29843420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
    J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of botulinum toxin A injection into the submandibular salivary glands as an assessment for the subsequent removal of the submandibular glands in the management of children with sialorrhoea.
    Sidebottom AJ; May JE; Madahar AK
    Br J Oral Maxillofac Surg; 2013 Mar; 51(2):113-6. PubMed ID: 22658501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study].
    Hernández-Palestina MS; Cisneros-Lesser JC; Arellano-Saldaña ME; Plascencia-Nieto SE
    Cir Cir; 2016; 84(6):459-468. PubMed ID: 27221328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
    Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands].
    Carod Artal FJ
    Neurologia; 2003 Jun; 18(5):280-4. PubMed ID: 12768517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases.
    Mazlan M; Rajasegaran S; Engkasan JP; Nawawi O; Goh KJ; Freddy SJ
    Toxins (Basel); 2015 Sep; 7(9):3758-70. PubMed ID: 26402703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.